Book a demo
Research & KnowledgeEvent: September 2, 2026

H1 published a new study testing LLMs on real-world clinical data to identify and assess patients against clinical trial eligibility criteria.

Published

Signal category

Research & Knowledge

Quote

A new study published yesterday tested LLMs on real-world clinical data to identify and assess patients against clinical trial eligibility criteria.

Brian M. White|H1 team

Company

H1

H1 is the connecting force for global HCP, clinical, scientific and research information.

Industry
Software Development
Location
New York, US
Company size
579 employees

H1 is on a mission to connect the world with the right doctors. H1’s AI-powered platform leverages a continuously learning Doctor Graph to identify and engage the right doctor for the critical needs in healthcare. It is built on one of the world’s largest and most comprehensive global datasets of healthcare professionals. By combining deep healthcare data with agentic AI workflows, H1 powers clinical research, medical exchange, patients finding doctors, health plan network analytics, and a system of record for provider data, helping create a healthier future for all.

Founded 2017

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.

H1 published a new study testing LLMs on real-world clinical data to identify and assess patients against clinical trial eligibility criteria. | SeedOps